Skip to content

Anterior Chamber Cells Grade 3 C4703388

Published: July 22, 2026Updated: August 20, 2026

Significant inflammation in the front chamber of the eye with grade 3 cell count. Affects vision and requires urgent ophthalmological assessment and anti-inflammatory treatment.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
H53.9
ICD-11
9A00.0
Body system
ophthalmologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Hypopyon

Generalized symptoms

(ophthalmologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Ocular pain

(ophthalmologic)

Photophobia

(ophthalmologic)

Headache

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Intensive Topical Corticosteroid Therapy

High-potency topical corticosteroid drops administered frequently initially to suppress intraocular inflammation. Tapered gradually based on clinical response and slit-lamp findings of cell reduction.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Cycloplegic Agent Therapy

Topical cycloplegic drops to prevent posterior synechiae formation, reduce ciliary spasm pain, and stabilize the blood-aqueous barrier during active inflammation.

medication

Additional treatment options

Anterior Chamber Tap or Paracentesis

Diagnostic or therapeutic removal of fluid from the anterior chamber to reduce inflammatory cell load, obtain diagnostic specimens, or lower intraocular pressure in severe cases.

procedure

Systemic Anti-inflammatory Therapy

Oral corticosteroids or immunosuppressive agents for severe cases not controlled with topical therapy alone. May include methotrexate, mycophenolate, or other steroid-sparing agents for long-term control.

medication

Serial Ophthalmologic Evaluation

Frequent slit-lamp examinations to document inflammatory cell grade, assess for complications including cataracts, glaucoma, or macular edema, and guide treatment adjustments.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anterior Chamber Cells Grade 3 C4703388?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Jabs DA, Dickersin J, Nussenblatt RB. Standardization of uveitis nomenclature for reporting clinical data:SUN working group recommendations. Arthritis Rheumatol. 2020.

guideline2020
2

Rathinam SR, Vedhanayalan R, Namperumalsamy P. Grading of anterior chamber inflammation in uveitis: clinical applications and correlation with treatment outcomes. Ocul Immunol Inflamm. 2019.

review2019
3

Galvin J, O'Neill BP, Rosenbaum JT. Comparative effectiveness of topical corticosteroids versus systemic anti-inflammatory therapy for anterior uveitis grade 3. JAMA Ophthalmol. 2021.

clinical_trial2021
4

Foster CS, Tugal-Tutkun I, Neri P. Immunomodulatory therapy for severe anterior segment inflammation: systematic review and meta-analysis. Surv Ophthalmol. 2022.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Anterior Chamber Cells Grade 3 C4703388. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy